Cardiotoxicity prevention trials in the era of contemporary cancer therapies: a systematic review.

Cardiooncology · 2026 · PMC13220620 · PMID 41965742

Europe PMC DOI

hedged sentence

0.0390

closest p · 0.8× alpha

0.0390

boldest claim

The sentences

an increasing trendP = 0.039actually significant

Using the RoB-2 tool, only 22 (23.9%) published trials had a low risk of bias (Figure S3), with an increasing trend over time (OR: 1.09; P = 0.039).

also in 38,133 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.